| References | Journal | Year | |
(2011) Nephrotoxicity of hexachloro-1:3-butadiene in the male Hanover Wistar rat; correlation of minimal histopathological changes with biomarkers of renal injury.
Swain, A., Turton, J., Scudamore, C., Maguire, D., Pereira, I., Freitas, S., Smyth, R., Munday, M., Stamp, C., Gandhi, M., Sondh, S., Ashall, H., Francis, I., Woodfine, J., Bowles, J., York, M. | J Appl Toxicol. | 2011 | View |
A Mouse GM-CSFR Antibody Attenuates Neutrophilia in Mice Exposed to Cigarette Smoke.
Botelho, F.M., Nikota, J., Bauer, C., Davis, N.H., S. Cohen, E., Anderson, I.K., Coyle, A.J., Kolbeck, R., Humbles, A.A., Stämpfli, M.R., Sleeman, M.A. | Eur Respir J. | 2011 | View |
A phase 2 study of pegylated interferon α-2b (PEG-Intron®) in children with diffuse intrinsic pontine glioma.
Warren, K., Bent, R., Wolters, P.L., Prager, A., Hanson, R., Packer, R., Shih, J., Camphausen, K. | Cancer. | 2011 | View |
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis.
Yellin M, Paliienko I, Balanescu A, Ter-Vartanian S, Tseluyko V, Xu LA, Tao X, Cardarelli PM, Leblanc H, Nichol G, Ancuta C, Chirieac R, Luo A. | Arthritis Rheum. | 2011 | View |
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma.
Wen, P.Y., Schiff, D., Cloughesy, T.F., Raizer, J.J., Laterra, J., Smitt, M., Wolf, M., Oliner, K.S., Anderson, A., Zhu, M., Loh, E., Reardon, D.A. | Neuro Oncol. | 2011 | View |
A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer.
Mohebtash, M., Tsang, K.Y., Madan, R.A., Huen, N.Y., Poole, D.J., Jochems, C., Jones, J., Ferrara, T., Heery, C.R., Arlen, P.M., Steinberg, S.M., Pazdur, M., Rauckhorst, M., Jones, E.C., Dahut, W.L., Schlom, J., Gulley, J.L. | Clin Cancer Res. | 2011 | View |
A pilot study to assess whether glucagon-like Peptide-1 protects the heart from ischemic dysfunction and attenuates stunning after coronary balloon occlusion in humans.
Read, P.A., Hoole, S.P., White, P.A., Khan, F.Z., O'Sullivan, M., West, N.E., Dutka, D.P. | Circ Cardiovasc Interv. | 2011 | View |
A Role for Decorin in a Murine Model of Allergen-Induced Asthma.
Marchica, C.L., Pinelli, V., Borges, M.C., Zummer, J., Narayanan, V., Iozzo, R.V., Ludwig, M.S. | Am J Physiol Lung Cell Mol Physiol. | 2011 | View |
A role for reactive oxygen species in endotoxin-induced elevation of MOR expression in the nervous and immune systems.
Langsdorf, E.F., Mao, X., Chang, S.L. | J Neuroimmunol. | 2011 | View |
A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis.
Davis, J.M. 3rd, Knutson, K.L., Strausbauch, M.A., Crowson, C.S., Therneau, T.M., Wettstein, P.J., Roger, V.L., Matteson, E.L., Gabriel, S.E. | Arthritis Rheum. | 2011 | View |
A Small Molecule That Mimics the BB-loop in the Toll Interleukin-1 (IL-1) Receptor Domain of MyD88 Attenuates Staphylococcal Enterotoxin B-induced Pro-inflammatory Cytokine Production and Toxicity in Mice.
Kissner, T.L., Moisan, L., Mann, E., Alam, S., Ruthel, G., Ulrich, R.G., Rebek, M., Rebek, J. Jr, Saikh, K.U. | J Biol Chem. | 2011 | View |
Abnormal peripheral chemokine profile in Huntington’s disease.
Wild, E., Magnusson, A., Lahiri, N., Krus, U., Orth, M., Tabrizi, S.J., Bjorkqvist, M. | PLoS Curr. | 2011 | View |
Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang, C., Zhao, M.L., Scearce, R.M., Diaz, M. | Arthritis Rheum. | 2011 | View |
Acute Exacerbations of COPD: Identification of Biological Clusters and Their Biomarkers.
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., Lindblad, K., Patel, H., Rugman, P., Dodson, P., Jenkins, M., Saunders, M., Newbold, P., Green, R.H., Venge, P., Lomas, D.A., Barer, M.R., Johnston, S.L., Pavord, I.D., Brightling, C.E. | Am J Respir Crit Care Med. | 2011 | View |
ADAM9 inhibition increases membrane activity of ADAM10 and controls αsecretase processing of amyloid precursor protein.
Moss, M.L., Powell, G., Miller, M.A., Bin, Q., Sang, Q.X., De Strooper, B., Tesseur, I., Lichtenthaler, S.F., Taverna, M., Zhong, J.L., Dingwall, C., Ferdous, T., Schlomann, U., Zhou, P., Griffith, L., Lauffenberger, D., Petrovich, R., Bartsch, J.W. | J Biol Chem. | 2011 | View |
Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes.
Bech, S., Hjermind, L.E., Salvesen, L., Nielsen, J.E., Heegaard, N.H., Jørgensen, H.L., Rosengren, L., Blennow, K., Zetterberg, H., Winge, K. | Parkinsonism Relat Disord. | 2011 | View |
An Endogenously Anti-Inflammatory Role for Methylation in Mucosal Inflammation Identified through Metabolite Profiling.
Kominsky, D.J., Keely, S., Macmanus, C.F., Glover, L.E., Scully, M., Collins, C.B., Bowers, B.E., Campbell, E.L., Colgan, S.P. | J Immunol Methods | 2011 | View |
Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism.
Cai, J., Hong, Y., Weng, C., Tan, C., Imperato-McGinley, J., Zhu, Y.S. | Am J Physiol Heart Circ Physiol. | 2011 | View |
Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis.
Kluve-Beckerman, B., Hardwick, J., Du, L., Benson, M.D., Monia, B.P., Watt, A., Crooke, R.M., Mullick, A. | Amyloid. | 2011 | View |
Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts.
Sithanandam, G., Fornwald, L.W., Fields, J.R., Morris, N.L., Anderson, L.M. | Int J Cancer. | 2011 | View |
Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis.
Krause, M.L., Davis, J.M. 3rd, Knutson, K.L., Strausbach, M.A., Crowson, C.S., Therneau, T.M., Wettstein, P.J., Matteson, E.L., Gabriel, S.E. | Clin Immunol. | 2011 | View |
Assessing the activity of cediranib, a VEGFR-2/3 tyrosine kinase inhibitor, against VEGFR-1 and members of the structurally related PDGFR family.
Brave SR, Ratcliffe K, Wilson Z, James NH, Ashton S, Wainwright A, Kendrew J, Dudley P, Broadbent N, Sproat G, Taylor S, Barnes C, Silva JC, Farnsworth CL, Hennequin L, Ogilvie DJ, Jürgensmeier JM, Shibuya M, Wedge SR, Barry ST. | Mol Cancer Ther | 2011 | View |
Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults.
Leng, S.X., Li, H., Xue, Q.L., Tian, J., Yang, X., Ferrucci, L., Fedarko, N., Fried, L.P., Semba, R.D. | Exp Gerontol. | 2011 | View |
Attenuated Abeta42 responses to low potency gamma-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds.
Kretner, B., Fukumori, A., Gutsmiedl, A., Page, R.M., Luebbers, T., Galley, G., Baumann, K., Haass, C., Steiner, H. | J Biol Chem. | 2011 | View |
Autophagy-dependent regulation of the DNA damage response protein ribonucleotide reductase 1.
Dyavaiah, M., Rooney, J.P., Chittur, S.V., Lin, Q., Begley, T.J. | Mol Cancer Res. | 2011 | View |